VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹280 Cr | ₹240 Cr | ₹185 Cr | ₹137 Cr | ₹69 Cr |
What is the latest Net Current Assets ratio of VENUS REMEDIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹280 Cr |
Mar2023 | ₹240 Cr |
Mar2022 | ₹185 Cr |
Mar2021 | ₹137 Cr |
Mar2020 | ₹69 Cr |
How is Net Current Assets of VENUS REMEDIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹280 Cr | 16.58 | |
Mar2023 | ₹240 Cr | 29.66 | |
Mar2022 | ₹185 Cr | 35.66 | |
Mar2021 | ₹137 Cr | 96.74 | |
Mar2020 | ₹69 Cr | - |
Compare Net Current Assets of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹424.0 Cr | 6.5% | 2.1% | -21.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 2.7% | -2.4% | 49.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,923.0 Cr | 2.9% | 6.2% | 64.2% | Stock Analytics | |
CIPLA | ₹121,796.0 Cr | 1% | 6.4% | 28.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,919.0 Cr | 1% | -2.3% | 6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,072.6 Cr | 2.4% | -1.1% | 53.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 6.5% |
2.1% |
-21.1% |
SENSEX | 0.2% |
-0.2% |
21.6% |
You may also like the below Video Courses